Skip to main content

Ernesto Trallero Araguas

Institutions of which they are part

Main researcher
Rheumatology
Vall Hebron Institut de Recerca

Ernesto Trallero Araguas

Institutions of which they are part

Main researcher
Rheumatology
Vall Hebron Institut de Recerca

Projects

Caracterización de las células patogénicas del músculo y piel de pacientes con Dermatomiositis y Síndrome Antisintetasa y estudio de aplicabilidad traslacional

IP: Ernesto Trallero Araguas
Collaborators: Miriam Izquierdo Sans
Funding agency: Fundación Española de Reumatología
Funding: 30000
Reference: FER/TRALLERO/2023
Duration: 21/10/2023 - 20/10/2024

Caracterización de las células patogénicas del músculo y piel de pacientes con Dermatomiositis y Síndrome Antisintetasa y estudio de aplicabilidad traslacional.

IP: Ernesto Trallero Araguas
Collaborators: Albert Selva O'Callaghan, Raul Tortosa Mendez, Albert Gil Vila, Gloria Aparicio Español, Adria Aterido Ballonga, Hugo Fernando Avalos Bogado
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI22/00708
Duration: 01/01/2023 - 31/12/2025

Inflitrado tumoral linfocitario (TIL) y dematomiositis asociada a cáncer.

IP: Albert Selva O'Callaghan
Collaborators: Ernesto Trallero Araguas, Maria Eugenia Semidey Raven
Funding agency: Instituto de Salud Carlos III
Funding: 129470
Reference: PI18/01609
Duration: 01/01/2019 - 30/06/2023

Identificación de nuevos antígenos en pacientes con miopatía inflamatoria

IP: Albert Selva O'Callaghan
Collaborators: Ernesto Trallero Araguas
Funding agency: Instituto de Salud Carlos III
Funding: 121000
Reference: PI15/02100
Duration: 01/01/2016 - 30/11/2020

Related news

Transaction expands Formation Bio's immunology pipeline with Phase 1 ready drug candidate.

15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations.

Funded by the European Union, this project coordinated by the Vall d'Hebron Research Institute (VHIR) seeks to develop more effective therapies by creating new combinations of existing drugs

Related professionals

Emily Betancourt Fernández

Emily Betancourt Fernández

Predoctoral researcher
Molecular Imaging and Therapy
Read more
Arturo Miguel Battaglia Cáceres

Arturo Miguel Battaglia Cáceres

Predoctoral researcher
Infectious Diseases
Read more
Berta Paez Montserrat

Berta Paez Montserrat

Predoctoral researcher
Neurovascular Diseases
Read more
Sara Mas Assens

Sara Mas Assens

Tècnic/a Grau Superior
Secretariat for Governance and Science Policy
Internal Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.